4th Quarter - Report — MAYO CLINIC for MAYO CLINIC (2018)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$250,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Opioid Epidemic (H.R. 6)

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 6 (115th)

Taxation/Internal Revenue Code TAX

Tax Reform; Tax Cuts and Jobs Act (H.R. 1)

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1 (115th)

Medical/Disease Research/Clinical Labs MED

Lab payments (PAMA); Research Funding; Regulatory Relief, Animal Welfare Act/Farm Bill (H.R. 2), Laboratory Diagnostic Tests

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2 (115th)

Science/Technology SCI

Telemedicine technology; New Diagnostic Tests; Precision Medicine, NextGen Sequencing

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Pharmacy PHA

Drug Shortage, Drug Pricing, Opioid Epidemic (H.R. 6), 340B Program

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 6 (115th)

Health Issues HCR

Telemedicine; Laboratory Medicine payment and oversight

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare physicians payments; Medicare hospital payments; Medicare clinical lab payments; Quality Issues; Telemedicine; Drug Pricing

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.